Hongli Group Inc. HLP
3.46 USD +0.10 (+2.98%)
Regular-session close
3.46 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
3.41 Day range 3.59
0.342 52-week range 4.90
- YTD
- +232.69%
- 1 year
- +127.63%
News
globenewswire.com Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder HLP003 achieved statistically significant and clinically meaningful results in the primary and key secondary endpoints starting as early as Day 2 and maintained at all time points -7.6 point…
globenewswire.com Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026 Company to host webcast at 8:00 a.m. EDT on Monday, November 16, 2026 Company to host webcast at 8:00 a.m. EDT on Monday, November 16, 2026
benzinga.com Intuitive Machines, Mobility Global, Fermi And Other Big Stocks Moving Higher On Thursday U.S. stocks were mixed as Nasdaq fell; Intuitive Machines surged 16% on strong Q3 results, while AEVEX and others posted gains.benzinga.com Hongli Group Announces Its In Talks With Current Xell Energy's Stockholders Regarding Definitive Share Purchase Agreement For Proposed Acquisition Of 20% Stake In Xell Hongli Group Inc. (the "Company") (Nasdaq: HLP), a cold roll-formed steel profile manufacturer advancing its strategic transition into high-growth clean energy sectors, today provided an update on its
